Sanofi says it hasn't increased its takeover bid for Genzyme

09/9/2010 | Boston Herald · Bloomberg Businessweek

Sanofi-Aventis said it is sticking with an $18.5 billion offer to take over Genzyme, dispelling a rumor that it increased its bid to more than $70 per share to woo the biotech firm's board members. Sanofi CEO Chris Viehbacher met with Genzyme's shareholders this week to pitch the $69-a-share offer, a spokesman said.

View Full Article in:

Boston Herald · Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations